New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Humacyte, Inc

Contributing Author

Recent Articles by Humacyte, Inc

Oct-07	Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering HUMA GlobeNewswire
Oct-06	Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess HUMA GlobeNewswire
Sep-29	Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus HUMA GlobeNewswire
Sep-18	Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG) HUMA GlobeNewswire
Sep-15	Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess HUMA GlobeNewswire
Aug-11	Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update HUMA GlobeNewswire
Aug-07	Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 HUMA GlobeNewswire
Jul-23	Humacyte Announces First Symvess Sale to Military Treatment Facility HUMA GlobeNewswire
Jul-08	Humacyte announces Symvess ECAT Approval from U.S. Defense Logistics Agency HUMA GlobeNewswire
Jun-09	Results from Humacyte's V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting HUMA GlobeNewswire
Jun-02	Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3 HUMA GlobeNewswire
May-19	Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq HUMA GlobeNewswire
May-13	Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update HUMA GlobeNewswire
May-09	Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025 HUMA GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.